1. Home
  2. YMAB vs GASS Comparison

YMAB vs GASS Comparison

Compare YMAB & GASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • GASS
  • Stock Information
  • Founded
  • YMAB 2015
  • GASS 2004
  • Country
  • YMAB United States
  • GASS Greece
  • Employees
  • YMAB N/A
  • GASS N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • GASS Marine Transportation
  • Sector
  • YMAB Health Care
  • GASS Consumer Discretionary
  • Exchange
  • YMAB Nasdaq
  • GASS Nasdaq
  • Market Cap
  • YMAB 192.4M
  • GASS 224.5M
  • IPO Year
  • YMAB 2018
  • GASS 2005
  • Fundamental
  • Price
  • YMAB $4.32
  • GASS $6.50
  • Analyst Decision
  • YMAB Buy
  • GASS
  • Analyst Count
  • YMAB 11
  • GASS 0
  • Target Price
  • YMAB $17.55
  • GASS N/A
  • AVG Volume (30 Days)
  • YMAB 182.8K
  • GASS 94.3K
  • Earning Date
  • YMAB 08-11-2025
  • GASS 09-04-2025
  • Dividend Yield
  • YMAB N/A
  • GASS N/A
  • EPS Growth
  • YMAB N/A
  • GASS 27.26
  • EPS
  • YMAB N/A
  • GASS 1.80
  • Revenue
  • YMAB $88,658,000.00
  • GASS $167,724,264.00
  • Revenue This Year
  • YMAB N/A
  • GASS $2.94
  • Revenue Next Year
  • YMAB $15.15
  • GASS $3.49
  • P/E Ratio
  • YMAB N/A
  • GASS $3.68
  • Revenue Growth
  • YMAB 4.92
  • GASS 14.07
  • 52 Week Low
  • YMAB $3.55
  • GASS $4.82
  • 52 Week High
  • YMAB $16.11
  • GASS $7.26
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 43.02
  • GASS 51.67
  • Support Level
  • YMAB $4.23
  • GASS $6.41
  • Resistance Level
  • YMAB $4.62
  • GASS $6.79
  • Average True Range (ATR)
  • YMAB 0.24
  • GASS 0.17
  • MACD
  • YMAB -0.03
  • GASS -0.04
  • Stochastic Oscillator
  • YMAB 14.04
  • GASS 44.23

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

Share on Social Networks: